돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1931621생성일: 2026년 10월 24일

Ethyl chloroformate → 4-[4-(4-Methanesulfonyl-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid ethyl ester

https://huagongshe.com/ko/reaction/1931621

반응식

참여 물질

역할이름HCID투입량
반응물Ethyl chloroformateHCID 10928—
반응물4-(4-methanesulfonyl-phenoxy)-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidine trifluoroacetate saltHCID 66915326—
생성물4-[4-(4-Methanesulfonyl-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid ethyl esterHCID 57964909—

반응 단계

4-[4-(4-Methanesulfonyl-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid ethyl ester was prepared according to General Procedure E by the reaction of 4-(4-methanesulfonyl-phenoxy)-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidine trifluoroacetate salt (Intermediate 27) with ethyl chloroformate (available from Aldrich Chemical Company, Inc., Milwaukee, Wis., USA). 1H NMR (400 MHz, DMSO-d6) δ 1.21 (t, 3H, J=7.1 Hz), 1.98-2.06 (m, 6H), 3.04-3.16 (m, 2H), 3.30 (methyl sulfonyl and water peak), 4.05-4.14 (m, 4H), 5.02-5.08 (m, 1H), 7.63-7.65 (m, 2H), 8.05-8.07 (m, 2H), 8.40 (s, 1H), 8.57 (s, 1H). Mass spectrum MH+=446.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08188098B2
출처 데이터셋uspto-grants-2012_05
ORD IDord-c036eb8a51674d1db289744313598404
출처 메모uspto-grants-2012_05